Alexandria Real Estate Equities Inc ARE
News
Alexandria Real Estate Equities, Inc. Highlights Its Role in Advancing Blood Cancer Innovation by Enabling Life-Changing Tenant R&D, Mission-Critical Philanthropic Initiatives and Strategic Investments
Alexandria Real Estate Equities, Inc. Declares Cash Dividend of $0.72 per Common Share for 3Q26
Alexandria Real Estate Equities, Inc. to Hold Its Third Quarter 2026 Operating and Financial Results Conference Call and Webcast on October 27, 2026
Alexandria Real Estate Equities, Inc. Announces Pricing of Public Offering of $1,000,000,000 of Series A Fixed-to-Fixed Reset Rate Junior Subordinated Notes due 2057
Alexandria Real Estate Equities, Inc. Reports 2Q26 and 1H26 Net (Loss) Income per Share - Diluted of $(0.43) and $1.68, respectively, and 2Q26 and 1H26 FFO per Share - Diluted, as Adjusted, of $1.73 and $3.46, respectively
Alexandria Real Estate Equities, Inc. Announces Foundational Milestone in Mission-Critical Partnership with the Foundation for the National Institutes of Health to Advance Precision Medicine for Depression
Alexandria Real Estate Equities, Inc. Delivers 427,000 RSF Innovative Research & Development Hub for a Multinational Pharmaceutical Company at the Campus Point by Alexandria Megacampus™ in San Diego
NOTICE: Investors in Alexandria Real Estate Equities, Inc. (NYSE: ARE) shares should contact the Shareholders Foundation in connection with Lawsuit
